Series 2 - A Diversified Fund of American Growth Fund, Inc.
About Us
Upcoming Events
Investment Strategy
Our Performance
Top Holdings
Industries in the Portfolio
Thoughts from Management
News & Media
Media
Recent News Articles
Cannabis by State
Invest Here
Literature
Prospectus
Current Annual or Semiannual Report
More Literature
Contact Us
Home
/
Our Portfolio
/ Cara Therapeutics Inc.
Cara Therapeutics Inc.
CARA
As of {tag_as of date}
Cara is developing lead molecules that selectively modulate peripheral CB receptors without targeting
CNS cannabinoid receptors.